CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by May 26, 2025 in order to receive your certificate. Certificates will be available online until September 1, 2025 and are printable directly from the website.
The Symposium will be reviewed by an accrediting organization and CME credit hours will be posted when available.
The 29th Annual Heart Failure 2025: An Update on Therapy continues the tradition of providing a comprehensive update on the prevention, diagnosis, and management of heart failure. The program includes lectures presented by experts combined with an opportunity for interactive discussion with faculty. The extensive list of topics has been selected to provide a contemporary, high level and clinically relevant update with a goal of improving clinicians’ knowledge and the care of patients with heart failure of various etiologies.
At the conclusion of this activity, participants should be able to:
The program has been designed to provide cardiologists, internists, primary care physicians, pharmacists, nurses and other healthcare providers with the necessary information to increase knowledge with the goal of improving the care of patients with HF.
Current estimates are that nearly 6.5 million Americans over the age of 20 have heart failure (HF) and there are 960,000 new cases annually. HF is one of the most common causes of cardiovascular mortality and severe morbidity. Recently developed and approved drugs and devices for the management of heart failure provide a great opportunity for improved outcome and need to be incorporated into the care of patients with heart failure. Recent data continues to show an important gap between published guideline recommendations for diagnosis and treatment of heart failure and practice (Journal of clinical medicine 2023; 12:1020) and demonstrates that life-saving drugs and devices are underutilized. Inadequate guideline directed medical therapy (GDMT) has been shown to confer a significant excess mortality (Clin Cardiol. 2021; 44:1192–1198). Most patients with HF are managed by non-cardiologist health care providers and providers without training in advanced heart failure ( Int J Cardiol 2021; 343:63) . Physicians’ education has been shown to result in a significant improvement in knowledge scales in HF care. (PLoS One2022 Feb 4;17(2): e0263523). Non-surgical, catheter-based repair of different valves is available to patients with heart failure who are at high risk for surgery. There is still underutilization of these procedures. (Cardiovasc Revasc Med 2022; 37:712) For all these reasons there is a need for education and incorporation of recent guidelines by clinicians. The 2024 symposium continues the tradition of almost 3 decades and has been designed to provide a comprehensive update on many of the new diagnostic and therapeutic modalities as well as information on new practice guidelines for the management of patients with HF.